Information Provided By: 
Fly News Breaks for December 6, 2018
TRHC
Dec 6, 2018 | 05:16 EDT
Piper Jaffray analyst Sean Wieland raised his price target for Tabula Rasa HealthCare to $80 after the company at its analyst day reiterated its 25% revenue growth outlook and target EBITDA margins of 20% but noted incremental investments in 2019 will keep EBITDA margins flat over the next 12 months. The analyst boosted his target multiple up to 5.5 times enterprise value to 2020 estimated revenue to "account for the success in the EMTM pilot and sustainability of revenue growth." He reiterates an Overweight rating on Tabula Rasa shares.
News For TRHC From the Last 2 Days
There are no results for your query TRHC
